Saltra Inhaler 125mcg/25mcg 1 ‘S
Description
- Saltra Inhaler 125mcg/25mcg 1 ‘S contains Salmeterol Xinafoate and Fluticasone Propionate which is a combination of steroid and bronchodilator used to treat Obstructive airway diseases
- Saltra Inhaler 125mcg/25mcg 1 ‘S is indicated in the treatment of Asthma, and Chronic Obstructive Pulmonary Diseases
- Saltra Inhaler 125mcg/25mcg 1 ‘S prevents asthma attacks and flare-ups in COPD associated with Emphysema or Chronic bronchitis
- Adults: 2 inhalations twice a day at lowest effective inhaled corticosteroid dose
- Children above 4 yrs: 2 inhalations of Saltra Inhaler 125mcg/25mcg 1 ‘S 25/50 preparation twice daily
Additional information
| Type | Inhaler – Device |
|---|---|
| Feature | 125mcg/25mcg |
| Unit | 'S |
| Formula | Fluticasone |
| Composition | Fluticasone 125 mcg + Salmeterol 25 mcg |
| Brand | Getz Pharma |
| Prescription Required | Yes |



